Document is current
Any future updates will be listed below
-
Authors
Shen, Liyue
Peng, Tao
Dong, Jiahui
Liang, Zhanwei
Si, Jihao
Ye, Hua
Xie, Jie
Yu, Xiaoping
Dai, Xinhua
-
Funding
Funding for this research was provided by:
the Plan for Leading Talents of Science and Technology Innovation (WR2202)
the National Key Research and Development program of China (2022YFF0608402)
- License Information
-
More Information
Article History
Received: 27 May 2024
Revised: 28 June 2024
Accepted: 1 July 2024
First Online: 10 July 2024
Declarations
:
: This study was approved by the Independent Ethics Committee of National GCP Center for Anticancer Drugs (NCC2020C-209) and was conducted from April 2020.
: The authors declare no competing interests.
